Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew K. Fust Insider Profile
4 Followers
Matthew K. Fust, Director at Ultragenyx Pharmaceutical, holds 20.10K shares in Neumora Therapeutics, Inc. (Ticker: NMRA), holds 20.20K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 21.94K shares in Crinetics Pharmaceuticals (Ticker: CRNX).
Matthew K. Fust Ultragenyx Pharmaceutical (RARE)Director
Ultragenyx Pharmaceutical (RARE)
Director
Ranked #7,491 out of 99,218 Corporate Insiders
Profitable Transactions
7 out of 12 Profitable Transactions
Average Return
+20.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew K. Fust holds in companies
Most Profitable Insider Trade
Stock:
Dermira
(~DERM)
(~DERM)
Rating:Informative Buy
Date:Nov 26, 2014 - Nov 26, 2015
Return:+69.50%
The most profitable trade made by Matthew K. Fust
Matthew K. Fust's Trading History
Ultragenyx Pharmaceutical
Jun 20, 2024
Director
Uninformative Buy
―
$1.02M
Crinetics Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
―
$1.33M
Neumora Therapeutics, Inc.
Oct 18, 2024
Director
Uninformative Buy
127.04K
$272.15K
Journey Medical Corp
―
Director
―
$96.34K
Dermira
Dec 26, 2019
―
Uninformative Sell
45.00K
$94.71K
MacroGenics
Feb 08, 2019
Director
Uninformative Buy
139.52K
$2.17K
Atara Biotherapeutics
Apr 02, 2024
Director
Uninformative Buy
―
$2.93M
Jazz Pharmaceuticals
―
EVP & CFO
―
$7.29M
Onyx Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Matthew K. Fust's performance on stock
You May Also Like
Matthew K. Fust insider profile FAQ
What is the percentage of profitable transactions made by Matthew K. Fust?
The percentage of profitable transactions made by Matthew K. Fust is 58%.
What is the average return per transaction made by Matthew K. Fust?
The average return per transaction made by Matthew K. Fust is 20.10%.
What stocks does Matthew K. Fust hold?
Matthew K. Fust holds: RARE, CRNX, NMRA, DERM, ~DERM, MGNX, ATRA, JAZZ, ONXX stocks.
What was Matthew K. Fust’s latest transaction?
Matthew K. Fust latest transaction was an Uninformative Buy of $127.04K.
What was Matthew K. Fust's most profitable transaction?
Matthew K. Fust’s most profitable transaction was an Informative Buy of ~DERM stock on November 26, 2014. The return on the trade was 69.50%.
What is Matthew K. Fust's role in Ultragenyx Pharmaceutical?
Matthew K. Fust's role in Ultragenyx Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.